Andrew D. Goldberg

TARS

Andrew D. Goldberg serves as Director at Tarsus Pharmaceuticals, Inc. (TARS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$19.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$19.0K

Companies Traded

TARS

Active Period

Dec 2023

1 total trades

Most Recent

Buy TARS

Dec 19, 2023 · $19.0K

Andrew D. Goldberg's Insider Trading at Tarsus Pharmaceuticals, Inc. (TARS)

Buys

1 · $19.0K

Sells

0 · $0.00

Total Shares Bought

1,000

Total Shares Sold

TARS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 19, 2023	Buy	1,000	$18.96	$19.0K	3,000

Related Insiders

Seshadri Neervannan

officer: Chief Operating Officer

TARSSell · Mar 24, 2026

Jeffrey S Farrow

See Remarks

TARSSell · Mar 19, 2026

Elizabeth Yeu Lin

officer: Chief Medical Officer

TARSSell · Mar 19, 2026

Aziz Mottiwala

officer: Chief Commercial Officer

TARSSell · Mar 19, 2026

Dianne C. Whitfield

officer: Chief Human Resources Officer

TARSSell · Mar 19, 2026

Bobak R. Azamian

President/CEO and Board Chair

TARSSell · Mar 19, 2026

Bryan Wahl

officer: General Counsel

TARSSell · Mar 19, 2026

LINK WILLIAM J PHD

Director

TARSSell · Mar 18, 2026

Explore More Insider Trading Data

TARS Insider Trading Activity

View all insider trades at Tarsus Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity